Literature DB >> 22309235

Rescue therapy for acute migraine, part 2: neuroleptics, antihistamines, and others.

Nancy E Kelley1, Deborah E Tepper.   

Abstract

OBJECTIVES: This second portion of a 3-part series examines the relative effectiveness of headache treatment with neuroleptics, antihistamines, serotonin antagonists, valproate, and other drugs (octreotide, lidocaine, nitrous oxide, propofol, and bupivacaine) in the setting of an emergency department, urgent care center, or headache clinic.
METHODS: MEDLINE was searched using the terms "migraine" AND "emergency" AND "therapy" OR "treatment." Reports were from emergency department and urgent care settings and involved all routes of medication delivery. Reports from headache clinics were only included if medications were delivered by a parenteral route.
RESULTS: Prochlorperazine, promethazine, and metoclopramide, when used alone, were superior to placebo. Droperidol and prochlorperazine were superior or equal in efficacy to all other treatments, although they also have more side effects (especially akathisia). Metoclopramide was equivalent to prochlorperazine and, when combined with diphenhydramine, was superior in efficacy to triptans and non-steroidal anti-inflammatory drugs. Meperidine was inferior to chlorpromazine and equivalent to the other neuroleptics. The overall percentage of patients with pain relief after taking droperidol and prochlorperazine was equivalent to sumatriptan.
CONCLUSIONS: Prochlorperazine and metoclopramide are the most frequently studied of the anti-migraine medications in the emergent setting, and the effectiveness of each is superior to placebo. Prochlorperazine is superior or equivalent to all other classes of medications in producing migraine pain relief. Dopamine antagonists, in general, appear to be equivalent for migraine pain relief to the migraine-"specific" medications sumatriptan and dihydroergotamine, although there are fewer studies involving the last two. Lack of comparisons to placebo and the frequent use of combination medications in treatment arms complicate the comparison of single agents to one other.
© 2012 American Headache Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22309235     DOI: 10.1111/j.1526-4610.2011.02070.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  11 in total

1.  Comparison of parenteral treatments of acute primary headache in a large academic emergency department cohort.

Authors:  Lucas H McCarthy; Robert P Cowan
Journal:  Cephalalgia       Date:  2014-11-03       Impact factor: 6.292

Review 2.  Cyclic vomiting syndrome: epidemiology, diagnosis, and treatment.

Authors:  Sanjay Bhandari; Pinky Jha; Abhishek Thakur; Abhipsa Kar; Harrison Gerdes; Thangam Venkatesan
Journal:  Clin Auton Res       Date:  2018-02-13       Impact factor: 4.435

3.  Metoclopramide versus sumatriptan in the treatment of migraine in the emergency department: a single-center, open-label, cluster-randomized controlled non-inferiority trial.

Authors:  Yumi Funato; Akio Kimura; Wataru Matsuda; Tatsuki Uemura; Kentaro Fukano; Kentaro Kobayashi; Ryo Sasaki
Journal:  Glob Health Med       Date:  2020-08-31

4.  Genetic Polymorphisms in the Dopamine Receptor 2 Predict Acute Pain Severity After Motor Vehicle Collision.

Authors:  Yawar J Qadri; Andrey V Bortsov; Danielle C Orrey; Robert A Swor; David A Peak; Jeffrey S Jones; Niels K Rathlev; David C Lee; Robert M Domeier; Phyllis L Hendry; Samuel A Mclean
Journal:  Clin J Pain       Date:  2015-09       Impact factor: 3.442

5.  Prevalence of headache in patients with Parkinson's disease and its association with the side of motor symptom onset.

Authors:  Jean Costa Nunes; E N Costa Bergamaschi; F C Freitas; A P Diaz; L P Queiroz; R Debona; R D S Prediger; M N Linhares; K Lin; Roger Walz
Journal:  Neurol Sci       Date:  2013-11-07       Impact factor: 3.307

Review 6.  Acute headache.

Authors:  Raeburn B Forbes
Journal:  Ulster Med J       Date:  2014-01

Review 7.  Targeting TRP channels for novel migraine therapeutics.

Authors:  Gregory Dussor; J Yan; Jennifer Y Xie; Michael H Ossipov; David W Dodick; Frank Porreca
Journal:  ACS Chem Neurosci       Date:  2014-08-29       Impact factor: 4.418

8.  Hospital Burden of Migraine in United States Adults: A 15-year National Inpatient Sample Analysis.

Authors:  Huay-Zong Law; Michael H Chung; George Nissan; Jeffrey E Janis; Bardia Amirlak
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-04-23

9.  Propofol alleviates intractable migraine headache: a case report.

Authors:  Masood Mohseni; Farzad Fatehi
Journal:  Anesth Pain Med       Date:  2012-09-13

10.  How transparent are migraine clinical trials? Repository of Registered Migraine Trials (RReMiT).

Authors:  Faustine L Dufka; Robert H Dworkin; Michael C Rowbotham
Journal:  Neurology       Date:  2014-09-05       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.